Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
7 days agoOpenAI Invests in Biodefense AI Startup Valthos to Combat Bioengineered Threats
OpenAI participated in a $30 million seed round for Valthos, a biodefense startup developing AI systems to detect and neutralize synthetic biological threats. Co-investors include Founders Fund and Lux Capital. The company’s platform applies multimodal AI to genomic datasets to predict and contain engineered pathogens before spread. Analysts call this OpenAI’s first venture into real-world AI safety and biosecurity applications.
positive
7 days agoOpenAI Invests in Biodefense AI Startup Valthos to Combat Bioengineered Threats
OpenAI participated in a $30 million seed round for Valthos, a biodefense startup developing AI systems to detect and neutralize synthetic biological threats. Co-investors include Founders Fund and Lux Capital. The company’s platform applies multimodal AI to genomic datasets to predict and contain engineered pathogens before spread. Analysts call this OpenAI’s first venture into real-world AI safety and biosecurity applications.
positive
OpenAI Invests in Biodefense AI Startup Valthos to Combat Bioengineered Threats
7 days ago
1 min read
60 words
OpenAI joins Founders Fund and Lux Capital in backing Valthos, an AI-powered biodefense startup combating engineered biological threats through predictive genomic modeling.
OpenAI participated in a $30 million seed round for Valthos, a biodefense startup developing AI systems to detect and neutralize synthetic biological threats. Co-investors include Founders Fund and Lux Capital. The company’s platform applies multimodal AI to genomic datasets to predict and contain engineered pathogens before spread. Analysts call this OpenAI’s first venture into real-world AI safety and biosecurity applications.
OpenAI participated in a $30 million seed round for Valthos, a biodefense startup developing AI systems to detect and neutralize synthetic biological threats. Co-investors include Founders Fund and Lux Capital. The company’s platform applies multimodal AI to genomic datasets to predict and contain engineered pathogens before spread. Analysts call this OpenAI’s first venture into real-world AI safety and biosecurity applications.
Tags:
OpenAI
Valthos
OpenAI
Valthos
AI
biotech
biosecurity
Oct 24, 2025 • 22:19 IST